Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01877083
Title Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Eisai Co., Ltd.
Indications

lung adenocarcinoma

Therapies

Lenvatinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST